.. Le-retentissement-de-la-maladie-sur-la-grossesse, 26 2.3.1. Le risque de fausse couche spontanée, ., p.26

L. Traitements-au-cours-de-la-grossesse and .. , Traitement associés aux anti-TNF-? en dehors des poussées, p.39

A. Xvi-au-cours-de-la and M. , Arbre décisionnel de la prise en charge des LAP, p.88

J. Lamoril, J. Deybach, and P. Bouizegarène, Maladie de Crohn et génétique: connaissances actuelles. Immuno-analyse & Biologie Spécialisée, 137?150. 3. de SAUSSURE P, BOUHNIK Y. Maladie de Crohn de l'adulte, 2007.

A. Cortot, G. Pineton-de-chambrun, G. Vernier-massouille, B. Vigneron, G. Rousseau et al., Maladies inflammatoires chroniques de l???intestin??: maladies g??n??tiques ou de l???environnement???, Gastroent??rologie Clinique et Biologique, vol.33, issue.8-9, pp.8-9681, 2009.
DOI : 10.1016/j.gcb.2009.07.005

M. Chauvet and A. Bourreille, Unité de Formation et de Recherche de Médecine et des Techniques Médicales, Ecole de sages-femmes (Nantes) Maladie de Crohn et grossesse, 2005.

E. Maria and C. Mousques, Microbiote et maladie de Crohn : états des lieux en 2011 : place du pharmacien dans la prise en charge. 3 févr 2012

S. Vermeire, F. Carbonnel, P. Coulie, V. Geenen, J. Hazes et al., Management of inflammatory bowel disease in pregnancy, Journal of Crohn's and Colitis, vol.6, issue.8, pp.811-823, 2012.
DOI : 10.1016/j.crohns.2012.04.009

J. Satsangi, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-753, 2006.
DOI : 10.1136/gut.2005.082909

M. Greff, F. Post-'u-fmc-hge-shanahan, C. V. Bernstein, F. Brazier, S. Debeugny et al., AFA -Calcul de l'indice CDAI de Best [Internet]. http://www.afa.asso.fr/ancien-site/documents/indice-Best.htm 11 The evolving epidemiology of inflammatory bowel disease al. Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors, ):301?305. 12. Russel MG243?249. 13. Lerebours E, 1998.

R. Russell, E. Nimmo, and J. Satsangi, A population-based case-control study):122?131. 14. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases New genes in inflammatory bowel disease: lessons for complex diseases?, 911?920. 15. Gaya DR,1271?1284. 16. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology, 2002.

J. Wehkamp, E. Stange, and K. Fellermann, Defensin-immunology in inflammatory bowel disease, Gastroent??rologie Clinique et Biologique, vol.33, pp.137-144, 2009.
DOI : 10.1016/S0399-8320(09)73149-5

A. Cuthbert, S. Fisher, M. Mirza, K. King, J. Hampe et al., The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease, Gastroenterology, vol.122, issue.4, pp.867-874, 2002.
DOI : 10.1053/gast.2002.32415

J. Halfvarson, L. Bodin, C. Tysk, E. Lindberg, and G. Järnerot, Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics, Gastroenterology, vol.124, issue.7, pp.1767-1773, 2003.
DOI : 10.1016/S0016-5085(03)00385-8

T. Jess, L. Riis, C. Jespersgaard, L. Hougs, P. Andersen et al., Disease Concordance, Zygosity, and NOD2/CARD15 Status: Follow-Up of a Population-Based Cohort of Danish Twins with Inflammatory Bowel Disease, The American Journal of Gastroenterology, vol.126, issue.11, pp.2486-2492, 2005.
DOI : 10.1111/j.1572-0241.2003.07240.x

D. Laharie, S. Debeugny, M. Peeters, A. Van-gossum, C. Gower-rousseau et al., Inflammatory bowel disease in spouses and their offspring, Gastroenterology, vol.120, issue.4, pp.816-819, 2001.
DOI : 10.1053/gast.2001.22574

L. Graff, N. Vincent, J. Walker, C. I. Carr, R. Ediger et al., A population-based study of fatigue and sleep difficulties in inflammatory bowel disease Lésions crohniennes de l'anus et du périnée -EMC-gastro-entérologie, ):1882?1889. 23. Bouguen G, pp.1-12, 2010.

E. Loridan, F. Machet, M. Happi-nono, C. Silvain, and J. Richer, Maladie de Crohn r??v??l??e par des l??sions anop??rin??ales : int??r??t de l??? IRM, 599?602. 25. Freeman H-J. Colorectal cancer risk in Crohn's disease, p.1810, 2004.
DOI : 10.1016/j.anchir.2004.06.009

J. Xie, J. Triantafillidis, G. Nasioulas, and P. Kosmidis, Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies Anticancer Res Disponible sur: http://www.getaid.org/03-fiches/fiches-medicaments.asp 29. Martin A-F, Troillard A. Place des biothérapies dans la prise en charge des MICI : étude rétrospective évaluant le profil et le type de prise en charge des patients traités par infliximab (efficacité et tolérance), Cancer in inflammatory bowel disease. World Journal of Gastroenterology Disponible sur, pp.378-405, 2000.

S. Buyse, S. Nahon, and P. Lahmek, Maladies inflammatoires chroniques de l'intestin et grossesse masson. Gastro-enterologie-Article, pp.9-37990

S. Couve, P. Seksik, E. Elefant, R. Jian, and P. Marteau, Maladies inflammatoires de l'intestin et procréation, Gastroenterol. Clin. Biol. juin, vol.27, pp.6-7618, 2003.

S. Couve, P. Seksik, E. Elefant, R. Jian, and P. Marteau, Inflammatory bowel disease and pregnancy, Gastroenterol. Clin. Biol. juin, vol.27, pp.6-7618, 2003.

U. Mahadevan, Fertility and pregnancy in the patient with inflammatory bowel disease, Gut, vol.55, issue.8
DOI : 10.1136/gut.2005.078097

D. Fedorkow, D. Persaud, and C. Nimrod, Disponible sur: http://www.lecrat.org/article.php3?id_article=657 35 Inflammatory bowel disease: a controlled study of late pregnancy outcome, Gut. août Am. J. Obstet. Gynecol. avr, vol.55160, issue.344, pp.998-1001, 1989.

L. Jeunne and C. , Risk of immunosuppressive drugs given throughout the pregnancy

M. Baudrant and A. Astier, Traitement de la recto-colite ulcérohémorragique et de la maladie de Crohn, Rev Med Interne. juin, vol.32, 2011.

E. Louis, Maladies inflammatoires chroniques de l'intestin Wolters Kluwer France, 2009.

M. Allez, Utilisation pratique des anticorps monoclonaux anti-TNF au cours des maladies inflammatoires de l???intestin, Gastroent??rologie Clinique et Biologique, vol.32, issue.5, pp.467-477, 2008.
DOI : 10.1016/j.gcb.2008.03.002

P. Amate, M. Seirafi, Y. Bouhnik, D. Luton, G. Ducarme et al., Gyn??cologie, obst??trique et maladies inflammatoires chroniques de l???intestin, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.40, issue.7, pp.612-619, 2011.
DOI : 10.1016/j.jgyn.2011.05.010

P. Gaudin, Faut-il avoir peur des anti-TNF?? en 2008???, La Revue de M??decine Interne, vol.29, issue.12, pp.971-974, 2008.
DOI : 10.1016/j.revmed.2008.04.022

H. Autorité-de-santé-ald, Disponible sur: http://www.has-sante.fr/portail/jcms/c_671094/ald-n-24-maladie-de-crohn 47 AFA -La carte URGENCE-TOILETTES pour les MICI. Disponible sur: http://www.afa.asso.fr/ancien-site/ACTurgen.htm 48

A. Rogers and S. Leiblum, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Inflammatory bowel disease in women: impact on relationship and sexual health, 413?421. 50. Van der Woude CJ, 2002.

S. Kane, B. Khatibi, D. Reddy, . Cw, J. Critchley et al., Higher incidence of abnormal Pap smears in women with inflammatory bowel disease Lack of association between cervical dysplasia and IBD: a large case-control study Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study Crohn's disease and pregnancy, 631?636. 52. Lees1621?1629. 53. Singh H, pp.451-458, 1984.

J. Mayberry, I. Weterman, P. Marteau, and E. Elefant, European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group., Gut, vol.27, issue.7, p.564, 1986.
DOI : 10.1136/gut.27.7.821

L. Abramowitz, . Maladie-de-crohn-et-grossesse, G. Benoist, J. Maurel, and M. Dreyfus, À propos de 34 cas Revue de la littérature Gynécologie Obstétrique & FertilitéInflammatory bowel disease and pregnancy: report of 76 cases and review of the literature], juill J Gynecol Obstet Biol Reprod, vol.3134, issue.6, pp.581-588, 2003.

U. Mahadevan, W. Sandborn, D. Li, S. Hakimian, S. Kane et al., Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California Données épidemiologiques générales liées à la grossesse donnees_epidemiologiques_generales_liees_a_la_grossesse .pdf. Disponible sur: http://www.has-sante.fr/portail, ):1106?1112. 61, pp.2003-2006724, 2007.

C. Mottet, P. Juillerat, J. Gonvers, F. Froehlich, B. Burnand et al., Pregnancy and Crohn’s Disease Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease, Digestion. Am. J. Gastroenterol. nov, vol.7190, issue.111, pp.54-61, 1995.

G. Serac, F. Tubach, M. X. Salmon-céron, D. Ravaud, P. Lioté et al., Risk of Herpes Zoster in Patients Receiving Anti-TNF-?? in the Prospective French RATIO Registry, Journal of Investigative Dermatology, vol.132, issue.3, pp.726-729, 2011.
DOI : 10.1038/jid.2011.383

D. Clark, Immunological factors in pregnancy wastage: fact or fiction, Am. J

D. Clark, COMMENTARY: Should Anti-TNF-?? Therapy be Offered to Patients with Infertility and Recurrent Spontaneous Abortion?*, American Journal of Reproductive Immunology, vol.204, issue.6 Suppl, pp.107-112, 2009.
DOI : 10.1111/j.1600-0897.2008.00680.x

B. Zhang, T. Liu, and Z. Wang, Association of tumor necrosis factor-?? gene promoter polymorphisms (-308G/A, -238G/A) with recurrent spontaneous abortion: a meta-analysis, Human Immunology, vol.73, issue.5
DOI : 10.1016/j.humimm.2012.01.008

U. Mahadevan, D. Wolf, M. Dubinsky, A. Cortot, S. Lee et al., Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register Annals of the Rheumatic Diseases A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease, ):603?605. 73. Disponible sur, 2009.

G. Ducarme, P. Amate, M. Seirafi, P. Ceccaldi, Y. Bouhnik et al., M??dicaments anti-TNF?? (tumor necrosis factor ??) en gyn??cologie et en obst??trique, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.40, issue.6, pp.492-497, 2011.
DOI : 10.1016/j.jgyn.2011.05.009

S. Kane, J. Ford, R. Cohen, and C. Wagner, Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohn??s Disease Before and After Delivery, Journal of Clinical Gastroenterology, vol.43, issue.7, pp.613-619, 2009.
DOI : 10.1097/MCG.0b013e31817f9367

?. Ben, S. Horin, M. Yavzori, L. Katz, O. Picard et al., Adalimumab Level in Breast Milk of a Nursing Mother Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease, 475?476. 78. Ben-Horin S, 2010.

J. Stengel, Is infl iximab safe to use while breastfeeding?, World Journal of Gastroenterology, vol.14, issue.19, p.3085, 2008.
DOI : 10.3748/wjg.14.3085

. Revue-de-la-littérature, Gynécologie Obstétrique & Fertilité, janv, vol.31, issue.1, pp.20-28, 2003.

M. Grossesse, cohorte observationnelle portant sur 120 patientes suivies dans des centres GETAID depuis le 1er janvier, 2009.

U. Mahadevan and S. Kane, Use of Infliximab in Pregnancy, The American Journal of Gastroenterology, vol.131, issue.1, pp.219-219, 2010.
DOI : 10.1038/ajg.2009.532

D. Beaulieu, K. S. Fonager, K. Sørensen, H. Olsen, J. Dahlerup et al., Inflammatory bowel disease in pregnancy Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries Epidemiology and Natural History of Inflammatory Bowel Diseases):1785?1794.e4. 89. Crohn_ulceration_aphtoide.jpg (Image JPEG, 647x639 pixels) -Redimensionnée (54%) Disponible sur: http://www.getaid.org/05- enseignement Disponible sur: http://www.getaid.org/05- enseignement/documents/Crohn_ulcerations_superficielles, 2426?2430. 88. Cosnes J,Crohn_ulceration_aphtoide.jpg 90. Crohn_ulcerations_superficielles.jpg (Image JPEG, 748x649 pixels) -Redimensionnée (53%), 1998.

R. Wallis, Tumour necrosis factor antagonists: structure, function, and tuberculosis risks, The Lancet Infectious Diseases, vol.8, issue.10, pp.601-611, 2008.
DOI : 10.1016/S1473-3099(08)70227-5

S. Kane and L. Acquah, Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy. The American Journal of Gastroenterology. 1 janv An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies, 228?233. 96. Pentsuk N, Van der Laan JW, pp.328-344, 2009.